학술논문
Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience
Document Type
Article
Author
Segman, Y.; Goldhecht, Y.; Sarid, N.; Benyamini, N.; Herishanu, Y.; Ram, R.; Perry, C.; Avivi, I.; Ribakovsky, E.; Avigdor, A.; Vainstein, V.; Goldschmidt, N.; Harlev, S.; Horwitz, N.; Gutwein, O.; Gurion, R.; Itchaki, G.; Abadi, U.; Nemets, A.; Sofer, O.; Zektser, M.; Tadmor, T.; Dally, N.; Filanovsky, K.; Leiba, M.
Source
In: Leukemia and Lymphoma . (Leukemia and Lymphoma, 2021, 62(1):118-124)
Subject
Language
English
ISSN
10292403
10428194
10428194